Trimoniums: CIR Safety Assessment Summary
CIR safety assessment summary for Trimoniums: ingredients reviewed, panel verdict, use concentration context, conditions, and source citation.
Trimoniums appears in a CIR safety assessment covering Trimoniums. The panel verdict for the report is safe with restrictions. The CIR Expert Panel concluded that the following ingredients are safe in the present practices of use and concentration described in this safety assessment (ingredients not in current use identified with an *), when formulated to be nonirritating: laurtrimonium bromide* laurtrimonium chloride myrtrimonium bromide cetrimonium chloride cetrimonium bromide cetrimonium methosulfate steartrimonium bromide*.
| Field | CIR value |
|---|---|
| Primary ingredient | Trimoniums |
| CIR verdict | safe with restrictions |
| Report type | Safety Assessment |
| Date | Empigen 5089 |
| CAS numbers | 1119-94-4, 112-00-5, 1119-97-7, 57-09-0, 112-02-7, 65060-02-8, 112-03-8, 18684-11-2, 17301-53-0, 81646-13-1, 61788-78-1, 61790-41-8, 8030-78-2, 61789-18-2, 103807-18-7 |
| Use concentration context | present practices of use and concentration described in the safety assessment |
| Conditions or carve-outs |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Trimoniums.
Safety Conclusion
The conclusion for Trimoniums should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
For use levels, the report gives this concentration context: present practices of use and concentration described in the safety assessment. That language is the safe-use context shown for this page.
Conditions
The CIR Expert Panel concluded that the following ingredients are safe in the present practices of use and concentration described in this safety assessment (ingredients not in current use identified with an *), when formulated to be nonirritating: laurtrimonium bromide* laurtrimonium chloride myrtrimonium bromide cetrimonium chloride cetrimonium bromide cetrimonium methosulfate steartrimonium bromide*.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Trimoniums, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Trimoniums should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Trimoniums, with source details retained at the bottom for audit.
Source
- CIR report: Safety Assessment of Trimoniums as Used in Cosmetics Lillian C. Becker1, Wilma F. Bergfeld2, Donald V. Belsito2, Ronald A. Hill2, Curtis D. Klaassen2, Daniel Liebler2, James G. Marks Jr2, Ronald C. Shank2, Thomas J. Slaga2,
- CIR source file: PRS572.pdf
- Extraction JSON: CIR Safety Assessment Database
- Conclusion page in CIR extraction: 41